Filing Details

Accession Number:
0001181431-11-022882
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-06 19:05:40
Reporting Period:
2011-04-06
Filing Date:
2011-04-06
Accepted Time:
2011-04-06 19:05:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1123494 Harvard Bioscience Inc HBIO Laboratory Analytical Instruments (3826) 043306140
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008643 David Green 84 October Hill Road
Holliston MA 01746
President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-04-04 1,000 $5.95 1,483,902 No 4 S Direct
Common Stock Disposition 2011-04-05 6,000 $6.04 1,477,902 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents shares sold by Mr. Green pursuant to a Sales Plan under Rule 10b5-1 adopted by the reporting person in September 2009.
  2. The shares were sold in multiple transactions at a price of $5.95.
  3. Includes (a) a deferred stock award of 100,200 restricted stock units which vest in equal installments on January 1, 2012; January 1, 2013 and January 1, 2014; and (b) 1,383,702 shares of common stock held by Mr. Green.
  4. Reflects the weighted average price of the shares sold in the reported transaction. These shares were sold in multiple transactions at prices ranging from $5.95 to $6.13, inclusive. The reporting person undertakes to provide to Harvard Bioscience, Inc., any security holder of Harvard Bioscience, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  5. Includes (a) a deferred stock award of 100,200 restricted stock units which vest in equal installments on January 1, 2012; January 1, 2013 and January 1, 2014; and (b) 1,377,702 shares of common stock held by Mr. Green.